The objective of the Fund is to achieve long-term capital growth through investment of at least two thirds of the total assets of the Fund in the equity securities of companies incorporated in the EEA or EU countries (excluding the United Kingdom) and Switzerland or in companies which derive a predominant proportion of their revenues or profits from these countries or which are predominantly operating in them.
Name | % Net Assets |
---|---|
Reed Elsevier N.V. | 2.4% |
Sanofi-Aventis S.A. | 2.2% |
Allianz SE | 2.2% |
Enagas S.A. | 2.1% |
Heineken N.V. | 2.0% |
Novartis AG | 2.0% |
Red Electrica Corp. S.A. | 1.9% |
Societe Generale S.A. (France) | 1.7% |
France Telecom | 1.6% |
Julius Baer Group AG | 1.4% |
Key | % Net Assets |
---|---|
Reed Elsevier N.V. | 2.4% |
Sanofi-Aventis S.A. | 2.2% |
Allianz SE | 2.2% |
Enagas S.A. | 2.1% |
Other | 91.1% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 28/05/2004 |
---|---|
Fund Manager | n/a |
TER | 1.00 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | 1460000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research